Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.76
Delayed Data
As of Aug 27
 +0.06 / +2.22%
Today’s Change
2.62
Today|||52-Week Range
9.37
-54.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash101.7M78.3M98.1M104.2M
 
 
 
 
 
Short Term Investment Cash76.8M-23.4M19.8M6.1M
 
 
 
 
 
Cash & Short Term Investments147.6M137.4M177.0M205.5M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.002.6M
 
 
 
InventoriesInventories0.000.000.001.2M
 
 
 
Current AssetsOther Current Assets1.1M1.5M1.3M2.0M
 
 
 
 
 
Current Assets148.7M138.9M178.3M211.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.1M2.0M2.6M2.9M
 
 
 
 
 
Depreciation-1.7M-1.9M-1.9M-2.1M
 
 
 
 
 
Other Assets0.000.001.0M621.0K
 
 
 
Total Assets149.7M139.2M180.1M213.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M3.8M4.8M4.2M
 
 
 
 
 
Accrued Expenses559.0K13.9M9.9M12.6M
 
 
 
 
 
Other Current Liabilities4.0M17.3M13.3M20.8M
 
 
 
 
 
Other Liabilities7.7M25.1M22.9M29.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0080.0M83.9M
 
 
 
Deferred Taxes0.000.000.00-547.0K
 
 
Other Liabilities288.0K0.00232.0K354.0K
 
 
 
 
Total Liabilities50.0M63.7M138.3M190.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity99.7M75.5M41.9M22.3M
 
 
 
 
 
Total Shareholder Equity99.7M75.5M41.9M22.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding61.3M84.4M105.0M123.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.